Advantages and complications of the administration of newer anticoagulants in geriatric patients with cardiore- spiratory diseases

Introduction: The number of patients taking anticoagulants due to the increased incidence of coronary heart disease has increased in recent decades. Newer anticoagulants have recently been used in the treatment of atrial fibrillation, pulmonary embolism and deep vein thrombosis.

The purpose of this study is to highlight the benefits and complications of administering newer anticoagulants to geriatric patients with cardiorespiratory disease.

Methodology: Data from studies, reviews and scientific articles in Pubmed and Mednet databases were used to write this review.

Results and conclusions: The calculation of the hemorrhagic risk as well as the ischemic events of the patients is of great importance in the decision-making for the individualization of the anticoagulation treatment. Newer oral anticoagulants offer better safety, easier use and effectiveness with the main advantage being the net clinical benefit over vitamin K blockers which increases with age in patients with Atrial Fibrillation.